多機能抗がん剤としてのイソトレチノイン:分子機構,薬理学的洞察,治療的可能性
Pritam Sarkar1, Nasrin Sultana1, Prottoy Kumar Debnath1
1Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
Archiv der Pharmazie
|September 3, 2025
まとめ
イソトレチノインは 腫瘍の成長を抑制し アポトーシスを誘発することで 癌の治療に有望であることが示されています よりアクセシブルな治療法のために,その使用を最適化し,毒性に対処するためにさらなる研究が必要です.
科学分野:
- 腫瘍学
- 薬理学について
- 薬物の再利用
背景:
- 従来のがん治療は 薬剤耐性 副作用 高額などの課題に直面しています
- 薬物の再利用は 既存の薬から新しい抗がん剤を 特定するための有望な手段です
研究 の 目的:
- イソトレチノインの化学,薬動性,毒性,および抗癌メカニズムをレビューする.
- 癌治療におけるイソトレチノインの役割を支持する臨床的および臨床前的証拠を調査する.
主な方法:
- 癌におけるイソトレチノインに関する臨床前および臨床研究の文献レビュー
- イソトレチノインの分子機構の分析,受容体の活性化と経路の調節を含む.
主要な成果:
- イソトレチノインは,腫瘍細胞の成長を効果的に抑制し,アポトーシスを誘導し,様々な癌の分化を調節する.
- メカニズムには,網膜酸受容体 (RAR) の活性化と腫瘍学的経路の抑制が含まれます.
- アイソトレチノインとの併用療法では,効果を向上させ,副作用を軽減する可能性がある.
結論:
- イソトレチノインは,複数のメカニズムを通して,抗がん剤として有意な可能性を示しています.
- より広範な臨床適用のために,投与量,配方,および毒性を最適化するためにさらなる研究が必要である.
- イソトレチノインの薬物再利用は より費用対効果の高いがん治療への道を開きます
関連する概念動画
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:27Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659